Source comparisons
Approved comparison material connected to this topic. Only stored records are displayed.
Comparison
Is GHK-Cu Better Than GHK Copper? (Active vs Inactive) GHK-Cu is the active, bioavailable form—GHK copper refers to the generic molecule. Stability, absorption, and formulation determine efficacy in research Most resear…
Source: realpeptides.coView comparison →Comparison
Pickart et al. (2012), Skin Pharmacology and Physiology 0.001%–0.01% (1–10 μM) In vitro, 72 hours Human dermal fibroblasts No cytotoxicity; 70% increase in collagen I synthesis; no oxidative stress markers Gold standard…
Source: realpeptides.coComparison
The table below compares properly chelated GHK-Cu against common 'GHK copper' formulations sold without chelation verification. These distinctions determine whether research outcomes align with published protocols. Rese…
Source: realpeptides.coComparison
Most researchers searching for GHK-Cu assume the terms are synonymous—they're not. GHK-Cu is the stabilised tripeptide-copper complex (glycyl-L-histidyl-L-lysine copper(II)), while 'GHK copper' can refer to unpaired pep…
Source: realpeptides.coComparison
Here's the honest answer: the distinction between GHK-Cu and 'GHK copper' exists because suppliers exploit researcher confusion to sell lower-grade material at research-grade prices. Properly chelated GHK-Cu costs more …
Source: realpeptides.coComparison
Safety data for GHK-Cu shifts dramatically when delivery moves from topical creams to invasive methods—microneedling, dermal rollers, or subcutaneous injection. Topical application limits absorption to the stratum corne…
Source: realpeptides.coComparison
Topical Cream (daily) 1–3% 1.2–2.8 <5% (mild, transient) Safest option for extended use—copper load stays within skin's clearance capacity Serum with Microneedling (monthly) 2–5% 8.7–12.1 12–19% (inflammation, dryness) …
Source: realpeptides.coComparison
GHK-Cu (0.05–2.0%) 1.8–2.2% Transient vasodilation; rare copper sensitivity Negligible through intact skin 4–8 hours Exceptionally safe profile. Irritation almost always formulation-related rather than peptide toxicity.…
Source: realpeptides.coComparison
The FDA does not approve cosmetic ingredients the way it approves drugs. It classifies products based on intended use, and that classification determines which regulatory pathway applies. A cosmetic is defined under 21 …
Source: realpeptides.coComparison
FDA does not pre-approve cosmetic ingredients the way it approves drugs. Instead, it applies a two-part test: (1) What is the product's intended use as communicated through labeling, marketing, and consumer perception? …
Source: realpeptides.coComparison
Understanding the GHK-Cu Cosmetic FDA approved status requires comparing it against other regulatory pathways and peptide classifications. The table below outlines the key distinctions between cosmetic-grade GHK-Cu, res…
Source: realpeptides.coComparison
United States (FDA) Legal as cosmetic ingredient Facility registration under MoCRA; adverse event reporting No explicit limit; market practice 0.001–1% No drug claims (treat, prevent, cure disease); no structure-functio…
Source: realpeptides.coComparison
GHK-Cu Copper delivery + direct gene transcription modulation ~4,000 genes (upregulation and downregulation balanced) Essential. Bioactivity requires Cu(II) complex 1–10 µM in vitro; 0.01–0.1% topical Gold standard for …
Source: realpeptides.coComparison
Refrigerated (2–8°C), amber vial, minimal headspace 28–30 days Slow oxidative degradation, minimal copper dissociation Standard storage for routine research use. Ideal balance of accessibility and stability Room tempera…
Source: realpeptides.coComparison
Topical (intact skin) 0.5%–5% 1.8–3.2% (mild dermatitis) None detected (<2 µg/dL change) Yes. 12-week trials with 6-month follow-up Safest route with decades of validation; minimal risk profile Topical (open wounds) 1%–…
Source: realpeptides.coComparison
GHK-Cu 8–24 months Injection site reaction (12%), mild erythema (8%) Copper chelation, gene expression modulation Research-grade compound (not FDA-approved as drug) Favorable. No cumulative toxicity signals in trials up…
Source: realpeptides.coComparison
To further clarify the distinction and its implications for the question 'is GHK-Cu legal,' let's compare the two primary contexts: Intended Use In vitro & in vivo (non-human) scientific study Topical application for sk…
Source: realpeptides.coComparison
GHK-Cu's safety profile has been evaluated across multiple administration routes and model systems. The table below synthesizes findings from peer-reviewed studies, regulatory assessments, and comparative peptide resear…
Source: realpeptides.coComparison
The legality of GHK-Cu in 2026 varies dramatically depending on how the product is categorized, marketed, and intended for use. The table below distills the regulatory distinctions that determine compliance. Research Us…
Source: realpeptides.coComparison
The distinction between a cosmetic and a drug under FDA rules is not based on the ingredient. It is based on the intended use, which the FDA determines primarily from marketing claims. The same molecule (GHK-Cu) can be …
Source: peptidesexplorer.com